Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hamer

Showing results (521-530 of 748) with videos related to

Pageof 75
Sort By:
The International Journal of Eating Disorders|August 29, 2013
NURTURE: development and pilot testing of a novel parenting intervention for mothers with histories of an eating disorderCristin D Runfola, Nancy L Zucker, Ann Von Holle, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2009
Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophreniaChristine E Marx, Richard S E Keefe, Robert W Buchanan, et al.
Neuroimage. Clinical|August 25, 2022
Resection of dominant fusiform gyrus is associated with decline of naming function when temporal lobe epilepsy manifests after the age of five: A voxel-based lesion-symptom mapping studyCaroline Reindl, Anna-Lena Allgäuer, Benedict A Kleiser, et al.
The Journal of Clinical Psychiatry|June 13, 2012
Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trialRichard S E Keefe, Sophia Vinogradov, Alice Medalia, et al.
Child and Adolescent Psychiatry and Mental Health|August 17, 2013
Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methodsGloria M Reeves, Courtney Keeton, Christoph U Correll, et al.
The American Journal of Psychiatry|September 17, 2008
Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) studyLinmarie Sikich, Jean A Frazier, Jon McClellan, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|August 2, 2007
Treatment of early-onset schizophrenia spectrum disorders (TEOSS): demographic and clinical characteristicsJean A Frazier, Jon McCLELLAN, Robert L Findling, et al.
Behaviour Research and Therapy|October 14, 2009
Childhood anxiety associated with low BMI in women with anorexia nervosaJocilyn E Dellava, Laura M Thornton, Robert M Hamer, et al.
Clinical Chemistry and Laboratory Medicine|May 14, 2024
Validation of the enhanced liver fibrosis (ELF)-test in heparinized and EDTA plasma for use in reflex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD)Koen C van Son, Anne-Marieke van Dijk, Stan Driessen, et al.
Epilepsia|October 19, 2013
Cavernoma-related epilepsy: review and recommendations for management--report of the Surgical Task Force of the ILAE Commission on Therapeutic StrategiesFelix Rosenow, Mario A Alonso-Vanegas, Christoph Baumgartner, et al.
Pageof 75

Showing results (521-530 of 748) with videos related to

Sort By:
Pageof 75
The International Journal of Eating Disorders|August 29, 2013
NURTURE: development and pilot testing of a novel parenting intervention for mothers with histories of an eating disorderCristin D Runfola, Nancy L Zucker, Ann Von Holle, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2009
Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophreniaChristine E Marx, Richard S E Keefe, Robert W Buchanan, et al.
Neuroimage. Clinical|August 25, 2022
Resection of dominant fusiform gyrus is associated with decline of naming function when temporal lobe epilepsy manifests after the age of five: A voxel-based lesion-symptom mapping studyCaroline Reindl, Anna-Lena Allgäuer, Benedict A Kleiser, et al.
The Journal of Clinical Psychiatry|June 13, 2012
Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trialRichard S E Keefe, Sophia Vinogradov, Alice Medalia, et al.
Child and Adolescent Psychiatry and Mental Health|August 17, 2013
Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methodsGloria M Reeves, Courtney Keeton, Christoph U Correll, et al.
The American Journal of Psychiatry|September 17, 2008
Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) studyLinmarie Sikich, Jean A Frazier, Jon McClellan, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|August 2, 2007
Treatment of early-onset schizophrenia spectrum disorders (TEOSS): demographic and clinical characteristicsJean A Frazier, Jon McCLELLAN, Robert L Findling, et al.
Behaviour Research and Therapy|October 14, 2009
Childhood anxiety associated with low BMI in women with anorexia nervosaJocilyn E Dellava, Laura M Thornton, Robert M Hamer, et al.
Clinical Chemistry and Laboratory Medicine|May 14, 2024
Validation of the enhanced liver fibrosis (ELF)-test in heparinized and EDTA plasma for use in reflex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD)Koen C van Son, Anne-Marieke van Dijk, Stan Driessen, et al.
Epilepsia|October 19, 2013
Cavernoma-related epilepsy: review and recommendations for management--report of the Surgical Task Force of the ILAE Commission on Therapeutic StrategiesFelix Rosenow, Mario A Alonso-Vanegas, Christoph Baumgartner, et al.
Pageof 75